Covishield
-
DCGI grants permission to Serum Institute to manufacture its COVID-19 vaccine ‘Covishield’
India | Jan 04, 2021, 11:02 AM ISTDrugs Controller General of India grants permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’. The Pune-based company earlier stated that ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
-
Govt approves 2 Covid vaccines: Who will get it first, process and more. All queries answered
India | Jan 04, 2021, 10:49 AM ISTIndia joins the league of countries that have approved their own vaccines against coronavirus. The two vaccines that have been granted nod for emergency use are -- AstraZeneca-Oxford and Bharat Biotech.
-
'Very safe': Serum Institute's Adar Poonawalla assures as Covishield gets approval
India | Jan 03, 2021, 07:55 PM ISTSerum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Sunday assured that the Covishield vaccine, which has received approval for restricted emergency use, is "very safe".
-
Political leaders, commoners react over emergency use approval to COVID-19 vaccines
News | Jan 03, 2021, 02:52 PM ISTTaking to Twitter, Congress MP Shashi Tharoor said, "The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous."
-
‘Watershed moment' in India’s famed battle against Covid, hails health minister Harsh Vardhan
India | Jan 03, 2021, 02:03 PM ISTHours after India's drugs regulator approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, Union Health Minister Dr. Harsh Vardhan on Sunday called it a "watershed moment" in India’s famed battle against COVID-19.
-
'Absolute rubbish': DCGI on impotency rumours, says Covid vaccines 110% safe
India | Jan 03, 2021, 01:17 PM ISTAs India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "absolute nonsense".
-
WHO welcomes first emergency use authorization to COVID-19 vaccine in India
India | Jan 03, 2021, 12:06 PM ISTThe approved vaccines will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with co-morbidities.
-
'Covishield' ready to roll out in coming weeks: Adar Poonawalla
India | Jan 03, 2021, 12:08 PM ISTPoonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.
-
Would make every Indian proud: PM Modi on DCGI's final approval to Covishield, Covaxin
India | Jan 03, 2021, 12:08 PM ISTCovid-19 vaccines- COVAXIN and COVISHIELD have been cleared for restricted use in emergency situation, DCGI, V G Somani said.
-
Covishield, Covaxin get govt's nod: DCGI's Full Statement
India | Jan 03, 2021, 12:07 PM ISTThe expert panel has recommended granting permission for restricted emergency use of 'Covaxin' in "public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.
-
Covid vaccine is here! Serum Institute, Bharat Biotech get approval
India | Jan 03, 2021, 11:56 AM ISTIn a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
-
Will India get Covid vaccines on Sunday? DCGI BIG announcement expected
News | Jan 02, 2021, 10:24 PM ISTThe Drug Controller General of India (DCGI) will address a press conference on Sunday (January 3) at 11 am and it is being expected that the drug controller watchdog may announce the approval of emergency use of two vaccines.
-
Confident of bringing vaccine around Makar Sankranti to defeat coronavirus: Yogi Adityanath
India | Jan 02, 2021, 06:02 PM ISTAs the nation conducted a dry run of the vaccination process ahead of an expected launch of a vaccine against coronavirus, Uttar Pradesh Chief Minister Yogi Adityanath Dry said he is confident that they will be able to bring the vaccine around Makar Sankranti and defeat coronavirus.
-
Does India have the doses to fulfil Phase-1 Covid vaccine goals?
India | Jan 02, 2021, 05:38 PM ISTGiven that India has set the goal of vaccinating 30 crore people with Covid-19 jabs by July, can the country procure enough doses to fulfil that goal?
-
Covid vaccination: Dry run across India, who will get it first, how to register | Key points
India | Jan 02, 2021, 05:06 PM ISTAs India gears up to launch the world's largest immunisation drive, almost all states and Union Territory (UT) governments, including the national capital, conducted a dry run on Saturday to assess their ability and readiness to administer Covid-19 shots to hundreds of millions of people, including many in remote corners of the country.
-
Oxford-AstraZeneca COVID-19 vaccine gets recommendation for emergency use
India | Jan 01, 2021, 11:28 PM ISTAn expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended to grant emergency use authorisation for the Oxford COVID-19 vaccine Covishield, being manufactured by Serum Institute of India, sources said on Friday.
-
No emergency approval for vaccine maker SII, Bharat Biotech yet | What we know
India | Dec 30, 2020, 11:15 PM ISTThe analysis of the additional data and information submitted by Serum Institute of India (SII) and Bharat Biotech is still being conducted by regulator Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee and their next meeting will be held on January 1.
-
Covishield: Serum Institute submits additional data for emergency approval
India | Dec 23, 2020, 11:58 AM ISTThe Serum Institute of India (SII) has submitted additional data required by the Drug Controller General of India (DCGI) for determining the safety and immunogenicity of its Covid-19 vaccine candidate, Covishield, sources privy to the development told IANS.
-
Covid vaccine coming soon! Serum Institute seeks emergency use nod for Covishield in India
News | Dec 07, 2020, 08:42 PM ISTCovishield is logistically feasible for distribution in India's both urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.
-
Serum Institute seeks emergency use nod for Covishield in India
India | Dec 07, 2020, 08:31 AM ISTCovishield is logistically feasible for distribution in India's both urban and rural parts as it can be stored at two to eight degrees Celsius, which is an ideal temperature for being kept in cold storages in the country.